LFCR's free cash flow for Q3 2023 was $12.05M. For the 2023 fiscal year, LFCR's free cash flow was decreased by $5.82M and operating cash flow was $-272.00K. See a summary of the company’s cash flow.

Cash Flow	TTM	May 23	May 22	May 21	May 20	May 19
Operating Cash Flow	$ -20.39M	$ -17.44M	$ -24.40M	$ 15.02M	$ -16.54M	$ 19.52M
Investing Cash Flow	$ -8.06M	$ -4.81M	$ 81.77M	$ -10.86M	$ -24.39M	$ -100.30M
Financing Cash Flow	$ 48.51M	$ 39.70M	$ -57.02M	$ -3.42M	$ 40.02M	$ 79.03M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 10.12M	$ 1.64M	$ 1.64M	$ 1.29M	$ 553.00K	$ 1.47M
Income Tax Paid Supplemental Data	$ 23.00K	$ 23.00K	$ 441.00K	$ -7.68M	$ -1.12M	$ -1.96M
Interest Paid Supplemental Data	$ 31.02M	$ 31.02M	$ 16.89M	$ 13.22M	$ 10.13M	$ 5.61M
Issuance Of Capital Stock	$ 4.82M	$ 4.82M	-	-	$ 30.00K	$ 327.00K
Issuance Of Debt	$ 1.87M	$ -2.93M	$ -56.23M	$ 7.47M	$ 41.77M	$ 79.91M
Repayment Of Debt	$ -185.23M	$ -184.38M	$ -131.34M	$ -262.53M	$ -105.03M	$ -39.09M
Free Cash Flow	$ -23.64M	$ -17.44M	$ -23.26M	$ 27.93M	$ -40.79M	$ -24.95M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Lifecore Biomedical Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing